However, the treatment of PD-L1 antibodies could partially alleviate the impaired ability of OT-1 CD8 + T cells to eliminate UPP1-overexpressing LLC-OVA tumor cells (Supplementary Fig. 10f, g). The gene discussed is CD8A; the disease is neoplasm.